CreatorsPublishersAdvertisers
View more in
Medical & Biotech

ShapeTX Earns $112 Million Series B to Support Gene Therapy Development Projects

biospace.com
 2021-07-15

Cover picture for the articleSeattle biotechnology firm Shape Therapeutics has announced that it generated $112 million from a recent Series B financing round it co-led with Decheng Capital and Breton Capital. The amount is intended to support the company's growing portfolio of RNA technologies and accelerate efforts to develop various treatment approaches in the gene therapy field.

www.biospace.com

Comments / 0

Comments / 0